Enanta Pharma (ENTA) Tops Q4 EPS by 14c

Enanta Pharma (NASDAQ: ENTA) reported Q4 EPS of ($0.87), $0.14 better than the analyst estimate of ($1.01). Revenue for the quarter came in at $15.13 million versus the consensus estimate of $15.97 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Rocket Lab launches U.S. Space Force mission in record 16 hours
• Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink